MARIANNE FILKA: Open Payments
NPI 1174525307 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 29 payments from 9 companies in 2025. Trend: 2023 $284 · 2024 $200 · 2025 $957
Food & beverage: $957
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $359 |
| Vanda Pharmaceuticals Inc. | 9 | $244 |
| Gilead Sciences, Inc. | 5 | $144 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| ABBVIE INC. | 2 | $47 |
| Braeburn Inc. | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Wegovy, FANAPT, Ozempic, HETLIOZ, REXULTI, Epclusa, BRIXADI, INSPIRE.
Industry payments across TN — which companies pay providers there.
